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Kidney Res Clin Pract 31 (2012) A16–A96A24These two groups were not different according to age, diabetes or
cardiovascular event history but had a signiﬁcant higher interdialytic weight
gain and protein intake. In the Cox model analysis the patient overall
mortality was related to age (po0.0001), to the W52W8 BW D (p¼0.017), to
the CRP level at W52 (p¼0.035) and to serum albumin at W52 (p¼0.036).
Hence weight gain during the ﬁrst year of HD treatment was found a strong
predictor of survival in HD patients. It was associated with a better food
intake whereas the patient case-mix was not different. These data highlight
the need for understanding what drives food intake in dialysis patients and
for careful nutritional follow-up and support in incident HD patients.
http://dx.doi.org/10.1016/j.krcp.2012.04.35532
BODY WEIGHT CHANGE DURING THE FIRST YEAR OF HEMODIALYSIS IS
INFLUENCED BY THE DRY WEIGHT QUEST
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Fluid overload, high blood pressure (BP) and nutrition disturbances may
improve after HD onset. However HD patients remain exposed to a high
risk of death. We report the relationship between the dry weight quest and
nutritional markers on the survival in incident HD patients.
Among a cohort including 308 patients stating HD therapy 251
(age¼65,8714,8 y.o.; F/M¼93/158; diabetes¼36%) survived at least one
year after dialysis onset and were followed for an average of 44,9 months.
During the ﬁrst 8 weeks, the prescribed BW decreased by 6.575.6% and
then started to increase again. From Week 8 (W8) to W52, the BW change
(D) wasþ1,977,4% (extremes:–24,6 toþ28,2%). Serum albumin and nPNA
changed respectively byþ7.8 andþ11.4%. (þ7.6% vs–3.6%, p¼0.0001). The
initial W8-W1 BW D (expressed as % of the BW at HD onset) was
signiﬁcantly correlated with the systolic BP D at W26 and W52
(respectively p¼0.0007 and 0.0033). It was also inversely correlated with
the D in serum albumin and nPNA (p¼0.002 and 0.04) but not with BW D
between W8 and W52. The W52W8-BW D and the W52-W1-systolic BP D
were signiﬁcantly correlated (r¼–0,14, p¼0.03). When the patients were
split in two groups according the median of systolic BP change (–20.8 vs
þ7.8%), the W52W8 BW D was signiﬁcantly higher in the group of the
larger systolic BP decrease (þ3.3 vs þ0.6%, p¼0.004).
Hence weight gain during the ﬁrst year of HD treatment that is a strong
predictor of survival in our experience (reported in another abstract) is
inﬂuenced by the dry weight quest. In our practice, the systolic BP decrease
is related to ﬂuid removal and is associated with better patient survival,
opposite to the reverse epidemiology concept. Further studies using
bioimpedance are necessary to conﬁrm that an optimal ﬂuid status may
improve the nutritional status in HD patients.
http://dx.doi.org/10.1016/j.krcp.2012.04.35633
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Purpose: It has been documented that a low protein diet (LPD) with
ketoacid analogues (one ketosterils /5 kg) can postpone dialysis therapy in
chronic kidney disease. The purpose of the study was to compare the
effects of residual renal function preservation between low dose (one
ketosterils /10 kg) and standard dose (one ketosterils /5 kg) ketoacid
analogues.
Methods: The study was a prospective, open-label, group-comparison
design. The duration was 6 months. Patients were enrolled in two hospitals
when the serum Cr more than 6 mg/dL (CKD stage 4,5). Then the enrolled
patients were randomized to three groups, LPD, LPDK1 (LPD þ standard
dose ketosterils), LPDK2 (LPD þ low dose ketosterils). The deﬁnition of
LPD was 0.6-0.8 gm of protein/kg body weight/day. The comparable
variables were routine hemogram, bio-chemistry data, iPTH, reciprocal Cr
(1/Cr), (eGFR), UN/Cr levels in 24-hr urine (UUN/UCr). The measurements
were performed in baseline and 6th month.
Results: Demographics of patients were LPD: 22 (M/F:10/12), 49.5 y/o,
BMI 21.573.3; LPDK1:21 (8/13), 53.6 y/o, BMI 22.773.5; LPDK2:37 (15/22), 62 y/o (p:o0.0001), BMI 25.874.7 (p:0.001). The signiﬁcant variables
in the baseline between groups as follows: BUN 76.2726.9, 70.6717.6,
94.0725.7 mg/dL (p:0.001); Cr 8.872.8, 8.071.4, 8.772.5 mg/dL (NS);
K 4.470.8, 4.770.7 4.970.8 mEq/L (p:0.047), albumin 4.670.4, 4.570.3,
4.070.4 gm/dL (p:o0.001). The levels of 1/Cr from baseline to the 6th
month in LPD, LPDK1, LPDK2 demonstrated a signiﬁcant decline: 0.13-
0.11, slope 0.0032; 0.13-0.11, slope -0.003; 0.13-0.12, slope 0.002.
However, levels of UUN/UCr and eGFR did not reveal signiﬁcant changes.
UUN/UCr: 5.76-5.88, slope 0.0195, 6.45-6.21, slope 0.0397, 6.27-
6.57, slope 0.05. eGFR: 6.16-5.77, slope 0.065; 6.19-5.35, slope 0.12;
5.73-5.41, slope 0.053.
Conclusions: The 6-month observation study showed low dose ketoacid
analogues combined with LPD had a beneﬁcial effect to slow down renal
function deterioration in CKD stage 4,5. However, the slope of 1/Cr levels in
low dose ketoacid analogues was less than that in standard dose ketoacid
analogues.
http://dx.doi.org/10.1016/j.krcp.2012.04.35734
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Recent clinical research strongly approves that low-protein diet
supplemented with keto-amino acid can effectively delay progression of type
2 diabetic nephropathy (DN). Anti-inﬂammation is one of these effects, but the
mechanism is still controversial. This study is designed to further explore roles
of ketogenic diets in regulation of inﬂammation status of type 2 DN. Twenty-
one patients with type 2 DN (mean age at 65.1477.34 years), were followed-
up for 52 weeks in this study. All patients were in CKD stages 3–4 with
glomerular ﬁltration rates 26–55ml/min/1.73 m2 and were all on a low-
protein diet containing 0.8 g protein/kg BW per day and 30–35 Kcal /kg BW per
day. The diet was randomly supplemented with keto-amino acids at a dosage
of 100 mg/kg BW per day in 10 patients, who were assigned into Group II.
Other 11 patients were assigned into Group I. At the end of this study, related
clinical data showed there was a signiﬁcant increase in the serum level of TNF-
a which could mediate inﬂammation systemically in Group I (from
230.25754.34 to 332.11 pg/ml, P o 0.01), but non-signiﬁcant increase in
Group II (from 224.59741.24 to 253.41731.28 pg/ml, P40.05). The level of
CRP, which is produced in response to inﬂammation, rose greatly in Group I
(from 7.571.07 to 20.473.72 ug/ml, P o 0.01), but decreased in Group II
(from 8.273.07 to 3.971.22 ug/ml, P o 0.01). The level of adiponectin, an
anti-inﬂammatory factor, was decreased in Group I (from 9.4270.8 to
7.6471.4 mg/ml, Po 0.05), but showed slight increase in Group II (9.0470.9
versus 10.4771.2¼ mg/ml, P40.05). Nutritional markers including serum
albumin, hemoglobin and basal metabolic index showed no malnutrition
happened during the follow-up period. In conclusion, low-protein diet
supplemented with keto-amino acids contribute to ameliorate inﬂammation in
the progression of type 2 diabetic nephropathy through regulating
inﬂammatory factors production, including TNF-a, CRP and adiponectin.
http://dx.doi.org/10.1016/j.krcp.2012.04.35835
IMPACT OF DIETARY PROTEIN EXCHANGE 0N PATIENT’S COMPLIANCE,
APPLICABILITY AND EFFICIENCY IN CHRONIC KIDNEY DISEASE
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The application of Low Protein Diet (LPD) in the treatment of CKD has been
more accepted by all medical stuffs nowadays. However, the diversity and
complexity of therapeutic diet as well as being difﬁcult to obtain more
detailed consultation have caused poor long-term maintenance and
compliance in most patients.To investigate patient’s compliance to dietary
therapy as well as the impact of Dietary Protein Exchange (DPE) on patient’s
compliance in CKD patients.To investigate patient’s self understanding and
prehension to educational resources on DPE in CKD patients.CKD patients are
diagnosed in clinics from 6 hospitals according to the random digits table. 200
enrolled patients are randomly divided into test groups and control groups
after signing the concent forms.Test groups:Face to face education of the
utilization of new DPE as well as attentions in follow-up is conducted by
